Howe & Rusling’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.3M | Buy |
34,807
+485
| +1% | +$144K | 0.67% | 46 |
|
|
2025
Q4 | $9.37M | Sell |
34,322
-251
| -0.7% | -$68.2K | 0.62% | 49 |
|
|
2025
Q3 | $9.34M | Buy |
34,573
+280
| +0.8% | +$76.2K | 0.64% | 49 |
|
|
2025
Q2 | $9.45M | Buy |
34,293
+877
| +3% | +$238K | 0.7% | 45 |
|
|
2025
Q1 | $8.86M | Sell |
33,416
-615
| -2% | -$152K | 0.75% | 42 |
|
|
2024
Q4 | $7.9M | Sell |
34,031
-771
| -2% | -$177K | 0.68% | 47 |
|
|
2024
Q3 | $7.68M | Sell |
34,802
-626
| -2% | -$130K | 0.66% | 51 |
|
|
2024
Q2 | $6.97M | Sell |
35,428
-193
| -0.5% | -$39.9K | 0.64% | 54 |
|
|
2024
Q1 | $7.67M | Buy |
35,621
+821
| +2% | +$172K | 0.73% | 46 |
|
|
2023
Q4 | $7.33M | Sell |
34,800
-1,006
| -3% | -$215K | 0.78% | 44 |
|
|
2023
Q3 | $7.17M | Buy |
35,806
+616
| +2% | +$122K | 0.85% | 40 |
|
|
2023
Q2 | $6.52M | Sell |
35,190
-4,810
| -12% | -$889K | 0.73% | 49 |
|
|
2023
Q1 | $7.66M | Buy |
40,000
+15,183
| +61% | +$2.75M | 0.91% | 38 |
|
|
2022
Q4 | $4.17M | Sell |
24,817
-21,891
| -47% | -$3.8M | 0.52% | 60 |
|
|
2022
Q3 | $8.27M | Sell |
46,708
-1,421
| -3% | -$281K | 1.1% | 29 |
|
|
2022
Q2 | $9.85M | Buy |
48,129
+5,910
| +14% | +$1.25M | 1.25% | 22 |
|
|
2022
Q1 | $10M | Buy |
42,219
+7,338
| +21% | +$1.72M | 1.16% | 27 |
|
|
2021
Q4 | $7.97M | Buy |
+34,881
| New | +$7.67M | 0.93% | 38 |
|
|
2021
Q1 | – | Sell |
-23
| Closed | -$4K | – | 958 |
|
|
2020
Q4 | $4K | Hold |
23
| – | – | ﹤0.01% | 657 |
|
|
2020
Q3 | $4K | Sell |
23
-17
| -43% | -$2.86K | ﹤0.01% | 587 |
|
|
2020
Q2 | $7K | Sell |
40
-27
| -40% | -$4.84K | ﹤0.01% | 473 |
|
|
2020
Q1 | $12K | Hold |
67
| – | – | ﹤0.01% | 400 |
|
|
2019
Q4 | $13K | Hold |
67
| – | – | ﹤0.01% | 434 |
|
|
2019
Q3 | $14K | Hold |
67
| – | – | ﹤0.01% | 427 |
|
|
2019
Q2 | $13K | Hold |
67
| – | – | ﹤0.01% | 417 |
|
|
2019
Q1 | $11K | Hold |
67
| – | – | ﹤0.01% | 434 |
|
|
2018
Q4 | $13K | Hold |
67
| – | – | ﹤0.01% | 405 |
|
|
2018
Q3 | $11K | Buy |
+67
| New | +$11.3K | ﹤0.01% | 484 |
|
|
2017
Q3 | – | Sell |
-25
| Closed | -$3K | – | 890 |
|
|
2017
Q2 | $3K | Buy |
+25
| New | +$2.99K | ﹤0.01% | 709 |
|
|
2016
Q1 | – | Sell |
-52
| Closed | -$5K | – | 1012 |
|
|
2015
Q4 | $5K | Hold |
52
| – | – | ﹤0.01% | 621 |
|
|
2015
Q3 | $5K | Hold |
52
| – | – | ﹤0.01% | 626 |
|
|
2015
Q2 | $5K | Buy |
+52
| New | +$4.85K | ﹤0.01% | 633 |
|
Other funds holding CME
VCM
VPM
Howe & Rusling's CME Position: Q1 2026 in Review
Howe & Rusling increased its CME Group (CME) stake by 1.4% in Q1 2026, buying an estimated $144K and bringing the position to 34,807 shares worth $10.3M. The position accounts for 0.67% of the portfolio, ranked #46.
Howe & Rusling first reported a position in CME in Q2 2015 and has held it in 32 quarters since. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Howe & Rusling held 34,807 shares of CME Group worth $10.3M as of Q1 2026.
- Howe & Rusling bought 485 CME Group shares in Q1 2026, an estimated $144K.
- CME Group made up 0.67% of Howe & Rusling's portfolio in Q1 2026, its #46 holding.
- Howe & Rusling first reported a position in CME Group in Q2 2015 and has held it in 32 quarters since.
- 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Howe & Rusling's 13F filing for Q1 2026, filed 28 Apr 2026.